Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Guardant Health Inc (NASDAQ: GH) was $46.74 for the day, up 1.39% from the previous closing price of $46.10. In other words, the price has increased by $1.39 from its previous closing price. On the day, 1.51 million shares were traded. GH stock price reached its highest trading level at $47.72 during the session, while it also had its lowest trading level at $46.0.
Ratios:
Our analysis of GH’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.36 and its Current Ratio is at 4.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on January 23, 2025, initiated with a Overweight rating and assigned the stock a target price of $60.
On June 28, 2024, Guggenheim Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $36.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 19 ’25 when Tariq Musa sold 116 shares for $43.70 per share. The transaction valued at 5,069 led to the insider holds 3,211 shares of the business.
Tariq Musa bought 116 shares of GH for $5,069 on Mar 19 ’25. On Mar 17 ’25, another insider, Kalia Kumud, who serves as the Chief Information Officer of the company, sold 3,500 shares for $43.16 each. As a result, the insider received 151,060 and left with 19,720 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 5768697856 and an Enterprise Value of 6264792064. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.81. Its current Enterprise Value per Revenue stands at 8.477 whereas that against EBITDA is -15.615.
Stock Price History:
The Beta on a monthly basis for GH is 1.43, which has changed by 1.6421707 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, GH has reached a high of $50.89, while it has fallen to a 52-week low of $15.81. The 50-Day Moving Average of the stock is 6.65%, while the 200-Day Moving Average is calculated to be 44.13%.
Shares Statistics:
GH traded an average of 2.37M shares per day over the past three months and 2323020 shares per day over the past ten days. A total of 123.99M shares are outstanding, with a floating share count of 117.96M. Insiders hold about 4.42% of the company’s shares, while institutions hold 96.26% stake in the company. Shares short for GH as of 1740700800 were 7897769 with a Short Ratio of 3.33, compared to 1738281600 on 5771757. Therefore, it implies a Short% of Shares Outstanding of 7897769 and a Short% of Float of 6.670000399999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
